In their ‘letter to the world’ they say that cancer is a ‘defining health issue of our time’ that requires a united and collective worldwide response on a par with Covid-19. The scientists argue that we’re at a ‘tipping point’ that could transform how we understand and treat cancer – but more support for life-saving research is required to beat the disease.
The letter is published as Cancer Research UK launched its More Research, Less Cancer campaign - the largest ever philanthropic campaign by a UK charity, which aims to raise £400m.
The charity warned that the number of global cancer cases are predicted to increase by around 50% by 2040. Domestically, 110,000 deaths could be avoided over the next two decades, if UK cancer mortality rates are reduced by 15% by 2040, CRUK revealed.
Chief Executive of Cancer Research UK, Michelle Mitchell OBE said:
“We stand on the brink of discoveries that will transform how we understand and treat cancer. Discoveries like new blood tests that detect cancer at an earlier stage, and algorithms that predict someone’s cancer risk and stop it from developing in the first place. These discoveries, that the research and scientific community are on the cusp of, have the potential to save and improve countless lives. But investment is needed. We’re partnering with more philanthropists than ever before, all of whom share our appetite for discovery and translating results into real patient benefit. But we need to go further. We need people with the means and vision to help us bring about a world where everybody can lead longer, better lives, free from the fear of cancer. That’s why we’ve launched our new campaign today. Because more support means more research, and more research means less cancer.”
Leading scientist Sir Paul Nurse, a Nobel Prize winning specialist in genetics and cell biology and chief executive officer of the Francis Crick Institute, is part of the coalition encouraging the world’s donors to invest in scientific endeavours that will continue to create revolutionary, cutting-edge solutions to cancer.
Sir Paul Nurse said:
“With the changes that we are witnessing with technological innovations, work can now be carried out much more quickly. In the next decade, therapies for children’s cancers can be revolutionised, blood tests and personal health data will allow for earlier detection of cancer whilst those with complex cancers will benefit from access to more personalised, life-saving treatments. But, if we are to continue making huge leaps in how we prevent, diagnose and treat cancer, we need the funds.”
Chair of Cancer Research UK, Lord Simon Stevens said:
“Philanthropy powers progress, enabling our researchers to take risks, challenge, and innovate. We’re in a golden age of scientific progress, with the potential to improve and save millions more lives. Few organisations in the world can rival Cancer Research UK’s global impact on cancer. We have the ideas and the expertise – now we need the financial firepower to seize these amazing opportunities and capitalise on our groundbreaking international partnerships.”
The money raised by the campaign will focus on work at the Francis Crick Institute, support the global cancer research initiative Cancer Grand Challenges, support scientists at every stage of their careers and enable more innovation that translates into effective therapies and diagnostics for patients.
The campaign comes at a time when philanthropists are being encouraged to give. Despite analysis by the Beacon Collaborative showing that generosity among wealthy people is increasing, a recent report by think-tank Onward pointed out that the wealthiest 10 per cent of households now donate half as much as a proportion of their income as those in the poorest 10 per cent, suggesting they could do much more to support charitable causes worldwide.
Cancer Research UK’s recent report Longer, Better Lives: A Manifesto for Cancer Research and Care said that urgent action was required to address a more than £1 billion funding gap for research into cancer over the next decade. The report said that excluding research funded by industry, charities fund 62% of cancer research, compared to government’s 38%.
Through the More Research, Less Cancer campaign, Cancer Research UK is looking to partner with philanthropists to support transformational research. The campaign has already seen significant investment from philanthropic donations, including generous support from The Chris Banton Foundation, The Kamini and Vindi Banga Family Trust and founder of Segantii Capital Management and owner of Blackpool Football Club Simon Sadler and his wife Gillian.
Simon Sadler said:
“Like so many of us, my family has been affected by cancer. It’s a devastating disease, but what the next decade of research could do, the advances that could be made, the lives that could be saved, is inspiring. But it needs investment. Cancer Research UK provided my wife and I an opportunity to fund some of the incredible work of the CRUK National Cancer Biomarker Centre in Manchester, where I went to university, helping researchers to develop blood tests to detect cancers earlier and make better decisions about the best course of treatment. We’re kept up to date with key progress and find it really rewarding thinking about the impact this could have on improving and saving lives in years to come.”
The More Research, Less Cancer campaign film can be seen here. Introduced by BBC journalist Victoria Derbyshire, the inspiring film brings together key figures in the cancer research community, united by their passion to progress life-saving research.
Source: CRUK
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.